AlphaFold 3

Predicting the structures and interactions of all of life's molecules with unprecedented accuracy.

by Isomorphic Labs · Drug Discovery AI

Executive Summary

AlphaFold 3 is an artificial intelligence and foundation model platform co-developed with Google DeepMind. It is capable of predicting the structures and interactions of all of life's molecules with unprecedented accuracy, marking a significant advancement in structural biology. This new AI model allows scientists to input a description of a biomolecular complex they are interested in, and it predicts the 3D structure of that complex. It accurately predicts the structure of proteins, DNA, RNA, ligands, and more, as well as how they interact. AlphaFold 3 is a powerful tool for rational drug design, offering a glimpse into the next generation of biological research and therapeutic development by enabling a deeper understanding of molecular biology.

Use Cases

  • Rational drug design and discovery
  • Predicting protein structures and interactions
  • Understanding DNA and RNA structures
  • Analyzing ligand binding and interactions
  • Accelerating therapeutic development

Features

Intelligence

  • 3D Structure Prediction: Accurately predicts the 3D structure of proteins, DNA, RNA, ligands, and other biomolecules.
  • Molecular Interaction Prediction: Predicts how different molecules interact with each other within a complex, including protein-ligand, protein-DNA, and protein-RNA interactions.

Pricing

Target Customer
Enterprise

About Isomorphic Labs

Isomorphic Labs is an AI-first drug design and development company, established as an Alphabet company. It leverages machine learning to reimagine and accelerate the drug discovery process, aiming to model complex biological phenomena to design novel molecules and develop innovative medicines.

Founded: 2021 · Headquarters: London, United Kingdom · Employees: 201-500 · Private